HTGC Stock Recent News

SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that the U.S. Small Business Administration (“SBA”) has approved its fourth Small Business Investment Company (“SBIC”) subsidiary, following the Company's prior receipt of i.

Hercules Capital (HTGC) closed the most recent trading day at $21.11, moving +0.24% from the previous trading session.

One reason to invest in stocks is to generate a stable income that can help finance your life without having to work all the time. This includes investing in high-dividend stocks.

Hercules Capital (HTGC) operates as a business development company that maintains a focus on life science and tech based companies. HTGC's high dividend yield of 7.5% and consistent dividend growth make it attractive for income investors. HTGC trades at a premium to NAV of over 82%, which is significantly above the 45% premium to NAV average.

Hercules Capital (HTGC) concluded the recent trading session at $20.28, signifying a +0.65% move from its prior day's close.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Hercules Capital is a high-quality BDC with strong NAV growth, but trades at a premium of over 70% to NAV. Portfolio risk ratings for HTGC are improving, with a decrease in weighted average risk grade for the second consecutive quarter. HTGC's dividend is well-covered by NII, but a recent decline in NII raises concerns about the sustainability of the premium valuation.

DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today announced that it entered into a secured loan facility for up to $150 million with Hercules Capital, Inc. (NYSE: HTGC) ("Hercules"). “This financing puts us in a strong position to advance our differentiated care model and take the lead as the industry continues to shift to value-based care,” said Mike Mikan, President and CEO of NeueHealth. “We have establishe.

In the latest trading session, Hercules Capital (HTGC) closed at $19.82, marking a +0.1% move from the previous day.

In the latest trading session, Hercules Capital (HTGC) closed at $19.57, marking a -0.15% move from the previous day.